At IngenBio, we aspire to be the leading private human pharmaceutical development company in the world. Our goal is to meet the pharmaceutical industry's increasing demands for more effectively targeted research and medicine.
Technology Transfer Alliance (TTA) is a collaborative process benefiting IngenBio and bio-defense agencies such as USAMRIID. The evolution of TTA since 1992 has made it increasingly easier for IngenBio laboratory scientists to bring funding, personnel, information, and resources into the USAMRIID community from outside sources through participation in the process. Outside sources may also realize these same benefits from the Command although government funding is strictly limited to specific arrangements when they participate in the process.